002064 华峰化学
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入20,372,5763.51%26,298,46125,884,10628,367,20214,723,883
减:营业总成本18,309,5933.58%23,744,13422,830,70619,227,95612,186,621
    其中:营业成本17,195,1524.42%22,262,19221,242,01917,388,87611,067,014
               财务费用(122,179)38.33%(145,582)(203,037)30,99263,795
               资产减值损失(2,582)101.39%(51,693)(89,624)(32,754)(35,110)
公允价值变动收益5,4462,345.87%(2,778)(2,342)(1,334)4,979
投资收益89,6427.54%93,504105,79369,51542,459
    其中:对联营企业和合营企业的投资收益79,343-6.67%100,71879,82659,36338,747
营业利润2,327,3287.57%2,768,0033,203,1599,247,2862,641,712
利润总额2,287,2617.36%2,618,8733,181,3539,156,4532,613,990
减:所得税费用267,70333.46%139,687339,4121,220,273335,226
净利润2,019,5584.64%2,479,1862,841,9407,936,1792,278,764
减:非控股权益4,940249.66%721(2,032)(516)(369)
股东净利润2,014,6184.46%2,478,4642,843,9727,936,6952,279,132

市场价值指针
每股收益 (元) *0.4105.13%0.5000.5801.7100.490
每股派息 (元) *----0.1500.1500.3000.100
每股净资产 (元) *5.2807.62%5.0224.6644.1022.497
审计意见 #--标准的无保留意见标准的无保留意见--标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容